Search This Blog

Tuesday, September 3, 2019

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

  • Combined company creates a commercial-stage, transatlantic diagnostics company focusing on data-driven solutions for molecular microbiology
  • Combined company to be headquartered in Gaithersburg, MD, USA
  • Transaction is supported by the boards of OpGen and Curetis
  • Transaction subject to approval by both companies’ shareholders and debt financing providers
  • Conference call scheduled for September 4, 2019, at 9:00 am Eastern / 3:00 pm Central European Time

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.